Skip to main content
Top
Published in: International Urology and Nephrology 11/2015

01-11-2015 | Nephrology - Review

Frailty phenotype and chronic kidney disease: a review of the literature

Authors: Carlos G. Musso, Jose R. Jauregui, Juan F. Macías Núñez

Published in: International Urology and Nephrology | Issue 11/2015

Login to get access

Abstract

Frailty is a construct originally coined by gerontologists to describe cumulative declines across multiple physiological systems that occur with aging and lead individuals to a state of diminished physiological reserve and increased vulnerability to stressors. Fried et al. provided a standardized definition for frailty, and they created the concept of frailty phenotype which incorporates disturbances across interrelated domains (shrinking, weakness, poor endurance and energy, slowness, and low physical activity level) to indentify old people who are at risk of disability, falls, institutionalization, hospitalization, and premature death. Some authors consider the presence of lean mass reduction (sarcopenia) as part of the frailty phenotype. The frailty status has been documented in 7 % of elderly population and 14 % of not requiring dialysis CKD adult patients. Sarcopenia increases progressively along with loss of renal function in CKD patients and is high in dialysis population. It has been documented that prevalence of frailty in hemodialysis adult patients is around 42 % (35 % in young and 50 % in elderly), having a 2.60-fold higher risk of mortality and 1.43-fold higher number of hospitalization, independent of age, comorbidity, and disability. The Clinical Frailty Scale is the simplest and clinically useful and validated tool for doing a frailty phenotype, while the diagnosis of sarcopenia is based on muscle mass assessment by body imaging techniques, bioimpedance analysis, and muscle strength evaluated with a handheld dynamometer. Frailty treatment can be based on different strategies, such as exercise, nutritional interventions, drugs, vitamins, and antioxidant agents. Finally, palliative care is a very important alternative for very frail and sick patients. In conclusion, since the diagnosis and treatment of frailty and sarcopenia is crucial in geriatrics and all CKD patients, it would be very important to incorporate these evaluations in pre-dialysis, peritoneal dialysis, hemodialysis, and kidney transplant patients in order to detect and consequently treat the frailty phenotype in these groups.
Appendix
Available only for authorised users
Literature
1.
go back to reference Roshanravan B, Khatri M, Robinson-Cohen C, Levin G, Patel KV, de Boer IH, Seliger S, Ruzinski J, Himmelfarb J, Kestenbaum B (2012) A prospective study of frailty in nephrology-referred patients with CKD. Am J Kidney Dis 60(6):912–921PubMedCentralCrossRefPubMed Roshanravan B, Khatri M, Robinson-Cohen C, Levin G, Patel KV, de Boer IH, Seliger S, Ruzinski J, Himmelfarb J, Kestenbaum B (2012) A prospective study of frailty in nephrology-referred patients with CKD. Am J Kidney Dis 60(6):912–921PubMedCentralCrossRefPubMed
4.
go back to reference Romero-Cabrera AJ (2011) Frailty and chronic diseases in the elderly. Int Mex 27(5):455–462 Romero-Cabrera AJ (2011) Frailty and chronic diseases in the elderly. Int Mex 27(5):455–462
5.
go back to reference Johansen KL, Chertow GM, Jin C, Kutner NG (2007) Significance of frailty among dialysis patients. J Am Soc Nephrol 18(11):2960–2967CrossRefPubMed Johansen KL, Chertow GM, Jin C, Kutner NG (2007) Significance of frailty among dialysis patients. J Am Soc Nephrol 18(11):2960–2967CrossRefPubMed
6.
go back to reference Bonanni A, Mannucci I, Verzola D, Sofia A, Saffioti S, Gianetta E, Garibotto G (2011) Protein-energy wasting and mortality in chronic kidney disease. Int J Environ Res Public Health 8(5):1631–1635PubMedCentralCrossRefPubMed Bonanni A, Mannucci I, Verzola D, Sofia A, Saffioti S, Gianetta E, Garibotto G (2011) Protein-energy wasting and mortality in chronic kidney disease. Int J Environ Res Public Health 8(5):1631–1635PubMedCentralCrossRefPubMed
7.
go back to reference Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA (2001) Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146–M156CrossRefPubMed Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA (2001) Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146–M156CrossRefPubMed
8.
go back to reference Walker SR, Gill K, Macdonald K, Komenda P, Rigatto C, Sood MM, Bohm CJ, Storsley LJ, Tangri N (2013) Association of frailty and physical function in patients with non-dialysis CKD: a systematic review. BMC Nephrol 22(14):228. doi:10.1186/1471-2369-14-228 CrossRef Walker SR, Gill K, Macdonald K, Komenda P, Rigatto C, Sood MM, Bohm CJ, Storsley LJ, Tangri N (2013) Association of frailty and physical function in patients with non-dialysis CKD: a systematic review. BMC Nephrol 22(14):228. doi:10.​1186/​1471-2369-14-228 CrossRef
10.
go back to reference Forciea M, Lavizzo-Mourey R, Schwab E (2000) Geriatric secrets. Hanley & Belfus, Philadelphia Forciea M, Lavizzo-Mourey R, Schwab E (2000) Geriatric secrets. Hanley & Belfus, Philadelphia
11.
go back to reference McAdams-DeMarco MA, Law A, Salter ML, Boyarsky B, Gimenez L, Jaar BG, Walston JD, Segev DL (2013) Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis. J Am Geriatr Soc 61(6):896–901PubMedCentralCrossRefPubMed McAdams-DeMarco MA, Law A, Salter ML, Boyarsky B, Gimenez L, Jaar BG, Walston JD, Segev DL (2013) Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis. J Am Geriatr Soc 61(6):896–901PubMedCentralCrossRefPubMed
12.
go back to reference Montero-Odasso M, Schapira M, Soriano ER, Varela M, Kaplan R, Camera LA, Mayorga LM (2005) Gait velocity as a single predictor of adverse events in healthy seniors aged 75 years and older. J Gerontol A Biol Sci Med Sci. 60(10):1304–1309CrossRefPubMed Montero-Odasso M, Schapira M, Soriano ER, Varela M, Kaplan R, Camera LA, Mayorga LM (2005) Gait velocity as a single predictor of adverse events in healthy seniors aged 75 years and older. J Gerontol A Biol Sci Med Sci. 60(10):1304–1309CrossRefPubMed
13.
go back to reference Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R, Cesari M, Chumlea WC, Doehner W, Evans J, Fried LP, Guralnik JM, Katz PR, Malmstrom TK, McCarter RJ, Gutierrez Robledo LM, Rockwood K, von Haehling S, Vandewoude MF, Walston J (2013) Frailty consensus: a call to action. J Am Med Dir Assoc 14(6):392–397PubMedCentralCrossRefPubMed Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R, Cesari M, Chumlea WC, Doehner W, Evans J, Fried LP, Guralnik JM, Katz PR, Malmstrom TK, McCarter RJ, Gutierrez Robledo LM, Rockwood K, von Haehling S, Vandewoude MF, Walston J (2013) Frailty consensus: a call to action. J Am Med Dir Assoc 14(6):392–397PubMedCentralCrossRefPubMed
14.
go back to reference Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M (2010) European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4):412–423PubMedCentralCrossRefPubMed Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M (2010) European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4):412–423PubMedCentralCrossRefPubMed
15.
go back to reference Buford TW, Anton SD, Judge AR, Marzetti E, Wohlgemuth SE, Carter CS, Leeuwenburgh C, Pahor M, Manini TM (2010) Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy. Ageing Res Rev 9(4):369–383PubMedCentralCrossRefPubMed Buford TW, Anton SD, Judge AR, Marzetti E, Wohlgemuth SE, Carter CS, Leeuwenburgh C, Pahor M, Manini TM (2010) Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy. Ageing Res Rev 9(4):369–383PubMedCentralCrossRefPubMed
16.
go back to reference Shastri S, Katz R, Rifkin DE, Fried LF, Odden MC, Peralta CA, Chonchol M, Siscovick D, Shlipak MG, Newman AB, Sarnak MJ (2012) Kidney function and mortality in octogenarians: cardiovascular Health Study All Stars. J Am Geriatr Soc 60(7):1201–1207PubMedCentralCrossRefPubMed Shastri S, Katz R, Rifkin DE, Fried LF, Odden MC, Peralta CA, Chonchol M, Siscovick D, Shlipak MG, Newman AB, Sarnak MJ (2012) Kidney function and mortality in octogenarians: cardiovascular Health Study All Stars. J Am Geriatr Soc 60(7):1201–1207PubMedCentralCrossRefPubMed
17.
go back to reference Feng L, Yap KB, Yeoh LY, Ng TP (2012) Kidney function and cognitive and functional decline in elderly adults: findings from the Singapore longitudinal aging study. J Am Geriatr Soc 60(7):1208–1214CrossRefPubMed Feng L, Yap KB, Yeoh LY, Ng TP (2012) Kidney function and cognitive and functional decline in elderly adults: findings from the Singapore longitudinal aging study. J Am Geriatr Soc 60(7):1208–1214CrossRefPubMed
18.
go back to reference Rifkin DE, Shlipak MG, Katz R, Fried LF, Siscovick D, Chonchol M, Newman AB, Sarnak MJ (2008) Rapid kidney function decline and mortality risk in older adults. Arch Intern Med 168(20):2212–2218PubMedCentralCrossRefPubMed Rifkin DE, Shlipak MG, Katz R, Fried LF, Siscovick D, Chonchol M, Newman AB, Sarnak MJ (2008) Rapid kidney function decline and mortality risk in older adults. Arch Intern Med 168(20):2212–2218PubMedCentralCrossRefPubMed
19.
go back to reference Tessari P, Deferrari G, Robaudo C, Vettore M, Pastorin N, De Biasi L, Garibotto G (1999) Phenylalanine hydroxylation across the kidney in humans. Kidney Int 56:2168–2172PubMed Tessari P, Deferrari G, Robaudo C, Vettore M, Pastorin N, De Biasi L, Garibotto G (1999) Phenylalanine hydroxylation across the kidney in humans. Kidney Int 56:2168–2172PubMed
20.
go back to reference Garibotto G, Valli A, Anderstam B, Eriksson M, Suliman M, Balbi M, Rollando D, Vigo E, Lindholm B (2009) The kidney is a major site of S-adenosylhomocysteine disposal in humans. Kidney Int 76:293–296CrossRefPubMed Garibotto G, Valli A, Anderstam B, Eriksson M, Suliman M, Balbi M, Rollando D, Vigo E, Lindholm B (2009) The kidney is a major site of S-adenosylhomocysteine disposal in humans. Kidney Int 76:293–296CrossRefPubMed
22.
go back to reference Sun DF, Zheng Z, Tummala P, Oh J, Schaefer F, Rabkin R (2004) Chronic uremia attenuates growth hormone-induced signal transduction in skeletal muscle. J Am Soc Nephrol 15:2630–2646CrossRefPubMed Sun DF, Zheng Z, Tummala P, Oh J, Schaefer F, Rabkin R (2004) Chronic uremia attenuates growth hormone-induced signal transduction in skeletal muscle. J Am Soc Nephrol 15:2630–2646CrossRefPubMed
23.
go back to reference Chen Y, Biada J, Sood S, Rabkin R (2010) Uremia attenuates growth hormone-stimulated insulin-like growth factor-1 expression, a process worsened by inflammation. Kidney Int 78:89–95CrossRefPubMed Chen Y, Biada J, Sood S, Rabkin R (2010) Uremia attenuates growth hormone-stimulated insulin-like growth factor-1 expression, a process worsened by inflammation. Kidney Int 78:89–95CrossRefPubMed
24.
go back to reference Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR (2001) Baltimore longitudinal study of aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 86:724–731CrossRefPubMed Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR (2001) Baltimore longitudinal study of aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 86:724–731CrossRefPubMed
25.
26.
go back to reference Bailey JL, Zheng B, Hu Z, Price SR, Mitch WE (2006) Chronic kidney disease causes defects in signalling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy. J Am Soc Nephrol 17:1388–1394CrossRefPubMed Bailey JL, Zheng B, Hu Z, Price SR, Mitch WE (2006) Chronic kidney disease causes defects in signalling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy. J Am Soc Nephrol 17:1388–1394CrossRefPubMed
27.
go back to reference Pupim LB, Flakoll PJ, Majchrzak KM (2005) Aftab Guy DL, Stenvinkel P, Ikizler TA. Increased muscle protein breakdown in chronic hemodialysis patients with type 2 diabetes mellitus. Kidney Int 68:1857–1865CrossRefPubMed Pupim LB, Flakoll PJ, Majchrzak KM (2005) Aftab Guy DL, Stenvinkel P, Ikizler TA. Increased muscle protein breakdown in chronic hemodialysis patients with type 2 diabetes mellitus. Kidney Int 68:1857–1865CrossRefPubMed
28.
go back to reference Vanholder R, Ringoir S (1993) Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review. J Am Soc Nephrol 3:1541–1554PubMed Vanholder R, Ringoir S (1993) Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review. J Am Soc Nephrol 3:1541–1554PubMed
29.
go back to reference Nguyen-Khoa T, Massay ZA, De Bandt JP, Kebede M, Salama L, Lambrey G, Witko-Sarsat V, Drüeke TB, Lacour B, Thévenin M (2001) Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Transpl 16:335–340CrossRef Nguyen-Khoa T, Massay ZA, De Bandt JP, Kebede M, Salama L, Lambrey G, Witko-Sarsat V, Drüeke TB, Lacour B, Thévenin M (2001) Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Transpl 16:335–340CrossRef
30.
go back to reference Panichi V, Migliori M, De Pietro S, Taccola D, Bianchi AM, Giovannini L, Norpoth M, Metelli MR, Cristofani R, Bertelli AA, Sbragia G, Tetta C, Palla R, Colombo R (2002) C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure. Nephron 91:594–600CrossRefPubMed Panichi V, Migliori M, De Pietro S, Taccola D, Bianchi AM, Giovannini L, Norpoth M, Metelli MR, Cristofani R, Bertelli AA, Sbragia G, Tetta C, Palla R, Colombo R (2002) C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure. Nephron 91:594–600CrossRefPubMed
31.
go back to reference Bao Y, Dalrymple L, Chertow GM, Kaysen GA, Johansen KL (2012) Frailty, dialysis initiation, and mortality in end-stage renal disease. Arch Intern Med 172(14):1071–1077PubMedCentralCrossRefPubMed Bao Y, Dalrymple L, Chertow GM, Kaysen GA, Johansen KL (2012) Frailty, dialysis initiation, and mortality in end-stage renal disease. Arch Intern Med 172(14):1071–1077PubMedCentralCrossRefPubMed
32.
go back to reference Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J (2004) Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int 65:1031–1040CrossRefPubMed Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J (2004) Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int 65:1031–1040CrossRefPubMed
33.
go back to reference Macías Núñez JF, Ghais Z, Bustamante J, Lopez-Novoa JM, Arrieta J, Barril G, Del Pino MD, Escaja C, Martín IM, Fernández Andrade C, García F, Núñez J, Onaindía JM, González J, Pérez-Prieto M, Fernández M, Lopez J, Santiago JM, Vicens M, Sousa F (2010) Evaluation of oxidant-antioxidant balance in patients on maintenance haemodialysis: a comparative study ofdialyzers membranes. Nephron Clin Pract 114(1):c67–c73CrossRefPubMed Macías Núñez JF, Ghais Z, Bustamante J, Lopez-Novoa JM, Arrieta J, Barril G, Del Pino MD, Escaja C, Martín IM, Fernández Andrade C, García F, Núñez J, Onaindía JM, González J, Pérez-Prieto M, Fernández M, Lopez J, Santiago JM, Vicens M, Sousa F (2010) Evaluation of oxidant-antioxidant balance in patients on maintenance haemodialysis: a comparative study ofdialyzers membranes. Nephron Clin Pract 114(1):c67–c73CrossRefPubMed
34.
go back to reference Huang CX, Tighiouart H, Beddhu S, Cheung AK, Dwyer JT, Eknoyan G, Beck GJ, Levey AS, Sarnak MJ (2010) Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients. Kidney Int 77:624–629PubMedCentralCrossRefPubMed Huang CX, Tighiouart H, Beddhu S, Cheung AK, Dwyer JT, Eknoyan G, Beck GJ, Levey AS, Sarnak MJ (2010) Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients. Kidney Int 77:624–629PubMedCentralCrossRefPubMed
35.
go back to reference Kutner NG, Zhang R, Huang Y, Wasse H (2014) Gait speed and hospitalization among ambulatory hemodialysis patients: USRDS special study data. World J Nephrol 3(3):101–106PubMedCentralCrossRefPubMed Kutner NG, Zhang R, Huang Y, Wasse H (2014) Gait speed and hospitalization among ambulatory hemodialysis patients: USRDS special study data. World J Nephrol 3(3):101–106PubMedCentralCrossRefPubMed
36.
go back to reference Arnold RM, Zeidel ML (2009) Dialysis in frail elders—a role for palliative care. N Engl J Med 361(16):1597–1598CrossRefPubMed Arnold RM, Zeidel ML (2009) Dialysis in frail elders—a role for palliative care. N Engl J Med 361(16):1597–1598CrossRefPubMed
37.
go back to reference Burns A, Davenport A (2010) Functional status of elderly adults receiving dialysis. N Engl J Med 362(5):468CrossRefPubMed Burns A, Davenport A (2010) Functional status of elderly adults receiving dialysis. N Engl J Med 362(5):468CrossRefPubMed
38.
go back to reference Jassal SV, Chiu E, Hladunewich M (2009) Loss of independence in patients starting dialysis at 80 years of age or older. N Engl J Med 361(16):1612–1613CrossRefPubMed Jassal SV, Chiu E, Hladunewich M (2009) Loss of independence in patients starting dialysis at 80 years of age or older. N Engl J Med 361(16):1612–1613CrossRefPubMed
39.
go back to reference Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE (2009) Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 361(16):1539–1547CrossRefPubMed Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE (2009) Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 361(16):1539–1547CrossRefPubMed
40.
go back to reference Roderick PJ (2011) Chronic kidney disease in older people: a cause for concern? Nephrol Dial Transpl 26(10):3083–3086CrossRef Roderick PJ (2011) Chronic kidney disease in older people: a cause for concern? Nephrol Dial Transpl 26(10):3083–3086CrossRef
41.
go back to reference Musso CG, Trigka K, Dousdampanis P, Jauregui J (2015) Therapeutic alternatives and palliative care for advanced renal disease in the very elderly: a review of the literature. Int Urol Nephrol 47(4):647–654CrossRefPubMed Musso CG, Trigka K, Dousdampanis P, Jauregui J (2015) Therapeutic alternatives and palliative care for advanced renal disease in the very elderly: a review of the literature. Int Urol Nephrol 47(4):647–654CrossRefPubMed
42.
go back to reference Johansen KL, Chertow GM, Jin C, Kutner NG (2007) Significance of frailty among dialysis patients. J Am Soc Nephrol 18(11):2960–2967CrossRefPubMed Johansen KL, Chertow GM, Jin C, Kutner NG (2007) Significance of frailty among dialysis patients. J Am Soc Nephrol 18(11):2960–2967CrossRefPubMed
43.
go back to reference Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ 173(5):489–495PubMedCentralCrossRefPubMed Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ 173(5):489–495PubMedCentralCrossRefPubMed
44.
go back to reference Jauregui JR, Kecskes C, Patiño O, Musso CG, Galich A, Rodota L (2012) Sarcopenia. A relevant entity in the very elderly. Rev Hop Ital B Aires 32(4):162–168 Jauregui JR, Kecskes C, Patiño O, Musso CG, Galich A, Rodota L (2012) Sarcopenia. A relevant entity in the very elderly. Rev Hop Ital B Aires 32(4):162–168
45.
go back to reference Painter P, Kuskowski M (2013) A closer look at frailty in ESRD: getting the measure right. Hemodial Int 17(1):41–49CrossRefPubMed Painter P, Kuskowski M (2013) A closer look at frailty in ESRD: getting the measure right. Hemodial Int 17(1):41–49CrossRefPubMed
46.
go back to reference Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K (2013) Frailty in elderly people. Lancet 381(9868):752–762. doi: 10.1016/S0140-6736(12)62167-9. Review. Erratum in: Lancet. 2013 Oct 19;382(9901):1328 Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K (2013) Frailty in elderly people. Lancet 381(9868):752–762. doi: 10.​1016/​S0140-6736(12)62167-9. Review. Erratum in: Lancet. 2013 Oct 19;382(9901):1328
47.
go back to reference Boirie Y, Gachon P, Cordat N, Ritz P, Beaufrère B (2001) Differential insulin sensitivities of glucose, amino acid, and albumin metabolism in elderly men and women. J Clin Endocrinol Metab 86:638–644CrossRefPubMed Boirie Y, Gachon P, Cordat N, Ritz P, Beaufrère B (2001) Differential insulin sensitivities of glucose, amino acid, and albumin metabolism in elderly men and women. J Clin Endocrinol Metab 86:638–644CrossRefPubMed
48.
go back to reference Katz S, Akpom CA (1976) A measure of primary sociobiological functions. Int J Health Serv 6:493–508CrossRefPubMed Katz S, Akpom CA (1976) A measure of primary sociobiological functions. Int J Health Serv 6:493–508CrossRefPubMed
49.
go back to reference Pianta TF, Kutner NG (1999) Improving physical functioning in the elderly dialysis patient: relevance of physical therapy. ANNA J 26(1):11–14PubMed Pianta TF, Kutner NG (1999) Improving physical functioning in the elderly dialysis patient: relevance of physical therapy. ANNA J 26(1):11–14PubMed
Metadata
Title
Frailty phenotype and chronic kidney disease: a review of the literature
Authors
Carlos G. Musso
Jose R. Jauregui
Juan F. Macías Núñez
Publication date
01-11-2015
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 11/2015
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-015-1112-z

Other articles of this Issue 11/2015

International Urology and Nephrology 11/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.